Verastem (VSTM) Interest Expenses (2017 - 2026)
Verastem (VSTM) posted quarterly Interest Expenses of $855000.0 for Q1 2026, down 28.27% year-over-year from $1.2 million in Q1 2025, and up 106.02% quarter-over-quarter from $415000.0 in Q4 2025.
Analysis
Verastem (VSTM) Interest Expenses (2017 - 2026) Analysis & Trends
Verastem's Interest Expenses history runs 16 years deep, the most recent figure standing at $855000.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 28.27% year-over-year to $855000.0; the TTM figure through Mar 2026 stood at $855000.0 (down 28.27% YoY), while the FY2025 annual figure was $6.4 million, up 39.5% from the prior year.
- Interest Expenses for Q1 2026 stood at $855000.0, up from $415000.0 in the prior quarter.
- The five-year high for Interest Expenses was $11.0 million in Q2 2025, with the low at $257000.0 in Q1 2022.
- The 5-year median for Interest Expenses is $1.1 million (2023), against an average of $1.9 million.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses plunged 96.61% in 2022, then soared 867.4% in 2025.
- Verastem's Interest Expenses stood at $724000.0 in 2022, then soared by 54.7% to $1.1 million in 2023, then climbed by 2.32% to $1.1 million in 2024, then slumped by 63.79% to $415000.0 in 2025, then surged by 106.02% to $855000.0 in 2026.
- Business Quant data shows VSTM's Interest Expenses at $855000.0 in Q1 2026, $415000.0 in Q4 2025, and $4.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Verastem | 789.92 Mn | 653.56 Mn | 36.32 Mn | 360,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 360,000.00 |
| Mar 31, 2026 | 382,000.00 |
| Dec 31, 2025 | 415,000.00 |
| Sep 30, 2025 | 319,000.00 |
| Jun 30, 2025 | 212,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 769,000.00 |
| Dec 31, 2022 | 724,000.00 |
| Sep 30, 2022 | 717,000.00 |
| Jun 30, 2022 | 640,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 7.98 Mn |